Allergan, Inc. Announces the JUVEDERM(R) 'Switch Up' Campaign Educating Women on the Positive Impact Small Changes Have on Personal Appearance
IRVINE, Calif., March 16 Allergan, Inc. (NYSE: AGN) has announced the national launch of the JuvEderm® "Switch Up" campaign, spearheaded by television personality Dayna Devon who will share ways to maintain a fresh appearance as women approach milestone birthdays. Devon, who turns 40 this month and is a mother of two young children, has developed an easy strategy for women to switch up their current routines and take advantage of effective medical aesthetic treatments including JUVEDERM® dermal filler, the number-one selling hyaluronic acid dermal filler in the United States.(1)
To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/allergan/41442/
(Photo: http://www.newscom.com/cgi-bin/prnh/20100316/MM64508 )
"I'm celebrating the 'big 4-0' this year so there's no better time than now to switch up my routine to help me look and feel like the best version of myself," said Dayna Devon. "As a mom, wife and TV host, I'm always on the go and have little time for myself but I still want to look my best. In my 30s, I began receiving treatment with a dermal filler when I noticed these deep lines starting to form around my nose and mouth that looked like two parentheses and couldn't be filled in with the creams I was using."
Devon continued, "When JUVEDERM® became available a few years ago, I switched because it has a smooth formulation and is the only dermal filler made of hyaluronic acid that is approved to last up to one year from initial treatment(2). Now a new formulation called JUVEDERM® XC includes lidocaine and is available, so I am even more excited about the treatment because I get the same smooth, natural-looking results with a more comfortable injection experience. Plus, I don't have to spend time waiting for the messy topical anesthetic to take effect."
Women who want to switch up their routines can become a "fan" of the official JUVEDERM® Facebook page to receive personal tips on how to maintain their best appearance from Dayna Devon every month. In addition to her experiences with JUVEDERM® treatment, Devon will also share tips on energizing fitness routines, making health a priority and expanding horizons with new hobbies to help women look and feel their best.
Derek Jones, M.D., renowned Los-Angeles based dermatologist, says milestone birthdays are the perfect time for patients to switch up their aesthetic routines. "Just like our bodies, skin changes as we age," said Dr. Jones. "One common complaint I hear from my patients in their 30s and 40s is the appearance of the pesky parentheses due to lost facial volume. To treat those lines, I have been recommending JUVEDERM® smooth-consistency dermal fillers for years and now JUVEDERM® XC with lidocaine offers my patients another reason to make the switch."
Robert Grant, president of Allergan Medical, a division of Allergan, Inc. said, "Our JuvEderm® 'Switch Up' campaign is a great way to educate women and men about hyaluronic acid dermal filler treatments and encourage them to have a dialogue with a licensed and trained aesthetic-specialty physician about clinically proven treatments that deliver on the promise to help treat wrinkles in the lower part of the face."
For more information about JUVEDERM® dermal fillers and to find a local physician, please visit www.Juvederm.com.
Important JUVEDERM® Information
JUVEDERM® injectable gel (including JUVEDERM® Ultra, JUVEDERM® Ultra Plus, JUVEDERM® Ultra XC, and JUVEDERM® Ultra Plus XC) is indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Side effects were usually mild to moderate lasting 7 days or less and included temporary injection site reactions like redness, pain, firmness, swelling and bumps. JUVEDERM® is not for people with severe allergies. For more information, please click on the "About Safety" link at www.juvederm.com, or call the Allergan Product Support line at 1-877-345-5372. JUVEDERM® injectable gel is available by prescription only.
About Dayna Devon
Dayna Devon is a longtime television personality, and former host and correspondent for the nationally syndicated entertainment show "Extra." She has been a regular entertainment commentator and celebrity guest host on CNN, Fox News Channel, MSNBC, "The View" and NBC's "Today." Devon currently lives in Los Angeles with her husband and two young children.
About Allergan, Inc.
Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential - to see more clearly, move more freely, express themselves more fully. The Company employs more than 8,300 people worldwide operates state-of-the-art R&D facilities and world-class manufacturing plants. In addition to its discovery-to-development research organization, Allergan has global marketing and sales capabilities with a presence in more than 100 countries.
This press release contains "forward-looking statements," including the statements by Dayna Devon, Dr. Jones and Mr. Grant, and other statements regarding the safety, effectiveness, adverse reactions, product availability, approval and market potential of JUVEDERM® injectable gel and JUVEDERM® injectable gel with lidocaine. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Allergan's expectations and projections. Risks and uncertainties include, among other things, general industry and medical device market conditions; technological advances and patents attained by competitors; challenges inherent in the research and development and regulatory processes; challenges related to new product marketing, such as the unpredictability of market acceptance for new products and/or the acceptance of new indications for such products; inconsistency of treatment results among patients; potential difficulties in manufacturing a new product formulation; general economic conditions; and governmental laws and regulations affecting domestic and foreign operations. Allergan expressly disclaims any intent or obligation to update these forward-looking statements except as required by law. Additional information concerning these and other risk factors can be found in press releases issued by Allergan, as well as Allergan's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in Allergan's 2008 Form 10-K and Allergan's Form 10-Q for the quarter ended September 30, 2009. Copies of Allergan's press releases and additional information about Allergan is available on the World Wide Web at www.Allergan.com or you can contact the Allergan Investor Relations department by calling (714) 246-4636.
© 2010 Allergan, Inc. Irvine, CA 92612. ® marks owned by Allergan, Inc.
JUVEDERM® is a mark owned by Allergan Industrie, SAS
(1) January-October 2009. Data on file, Allergan, Inc., November 2009; US Facials Injectable Market Share Report; GuidePoint Global Filler Share Tracker.
(2) In clinical studies with up to one year results, most subjects acquired optimal correction at initial treatment. Some subjects required up to two touch-ups to achieve optimal correction.
SOURCE Allergan, Inc.
You May Also Like